parthenolide has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Liu, Q; Wang, W | 1 |
| Butini, S; Campiani, G; Carullo, G; Federico, S; Gemma, S; Papa, A; Pozzetti, L; Relitti, N | 1 |
1 review(s) available for parthenolide and Metabolic Diseases
| Article | Year |
|---|---|
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.
Topics: Animals; Antineoplastic Agents; Communicable Diseases; Drug Delivery Systems; Humans; Hypoglycemic Agents; Immunity, Innate; Metabolic Diseases; Neoplasms; Protein Structure, Secondary; Toll-Like Receptors | 2020 |
1 other study(ies) available for parthenolide and Metabolic Diseases
| Article | Year |
|---|---|
Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway.
Topics: Animals; Disease Models, Animal; Fibrosis; Hippo Signaling Pathway; Inflammation; Lipid Metabolism; Male; Metabolic Diseases; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Protein Serine-Threonine Kinases; Sesquiterpenes; Signal Transduction | 2021 |